Biothea
Biothea Pharma Inc.
- Business Model
- B2B
- Website
- biotheapharma.com
- Total Funding
- $22.0M
- Last Round
- $22.0M Venture RoundJan 2018
- Rounds
- 1
About
Biothea Pharma develops needle-free treatments for severe allergic reactions and anaphylaxis, offering convenient and cost-effective alternatives for healthcare providers.
Summary
Biothea is a Biotech company. It has raised $22.0M in total across 1 round, most recently a $22.0M Venture Round round in Jan 2018. Investors include Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2018
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.